News

STORM Therapeutics and the University of Cambridge receive Innovate UK funding to help the fight against cancer

STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, and The University of Cambridge announced today that they have been granted a Knowledge Transfer Partnership (KTP). The Grant, of up to £240,000, is to develop an analysis platform using the data warehouse software InterMine to help STORM advance its cancer research.

Read more

STORM Therapeutics to present at Bio€quity Europe 2018

STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced that it will be giving a company presentation at Bio€quity Europe 2018, Ghent, Belgium, 14 - 16 May 2018.

Read more

STORM Therapeutics wins Life Science Innovation Award

STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced that it has won the Life Science Innovation Award at the Business Weekly Awards ceremony.

Read more

Award Winning